Akoya, Zeiss to comarket spatial phenotyping and discovery workflow

By The Science Advisory Board staff writers

May 17, 2021 -- Akoya Biosciences and Zeiss are comarketing Akoya's codetection by indexing (CODEX) spatial phenotyping systems with Zeiss' Axio Observer microscope.

CODEX combines single-cell biology and histology in such a way that it can be integrated onto existing microscopy platforms. The technology allows for the multiplexed detection of 40 or more biomarkers in tissue samples and reveals different cell phenotypes, how they interact, and how they organize. The technology could advance biological research for cancer, immunology, developmental biology, and neurology, the firms added.

The partnership will allow Akoya and Zeiss to enhance workflows and speed up acquisitions, they said.

In other news, Akoya also opened the application process for the Imaging Innovators Network (I2 Network), a group of researchers who are selected based on their ideas for using CODEX. Researchers can apply to participate in the I2 Network.

Akoya Biosciences seeks Imaging Innovators Network researchers
Akoya Biosciences is looking for researchers to join its new Imaging Innovators (I2) Network, a collaborative initiative that aims to support...
Recent Developments in Advanced Microscopy
The past year has yielded exciting improvements in advanced microscopy technologies, including confocal, multiphoton, light sheet fluorescence and other...

Copyright © 2021 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter